{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:08:39Z","timestamp":1792084119656,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T00:00:00Z","timestamp":1271894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s12640-010-9192-0","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T15:04:54Z","timestamp":1271862294000},"page":"243-252","source":"Crossref","is-referenced-by-count":12,"title":["Stereotypic Progressions in Psychotic Behavior"],"prefix":"10.1007","volume":"19","author":[{"given":"Richard M.","family":"Kostrzewa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Anna","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence P.","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Brus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,22]]},"reference":[{"key":"9192_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-3565(25)21630-5","volume":"231","author":"GR Breese","year":"1984","unstructured":"Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA (1984) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 231:343\u2013354","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3565(25)23963-5","volume":"235","author":"GR Breese","year":"1985","unstructured":"Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA (1985a) Evidence that D1 dopamine receptors contribute to the supersensitive behavioral responses induced by l-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J Pharmacol Exp Ther 235:287\u2013295","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)23467-X","volume":"234","author":"GR Breese","year":"1985","unstructured":"Breese GR, Napier TC, Mueller RA (1985b) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234:447\u2013455","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(25)22697-0","volume":"240","author":"GR Breese","year":"1987","unstructured":"Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA (1987) 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into the nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240:167\u2013176","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR5","volume-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"LL Brunton","year":"2006","unstructured":"Brunton LL, Lazo JS, Parker KL (2006) Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics, 11th edn. McGraw Hill, New York","edition":"11"},{"key":"9192_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0022-3565(25)38471-5","volume":"268","author":"R Brus","year":"1994","unstructured":"Brus R, Kostrzewa RM, Perry KW, Fuller RW (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther 268:231\u2013237","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0091-3057(94)00328-9","volume":"50","author":"R Brus","year":"1995","unstructured":"Brus R, Plech A, Kostrzewa RM (1995) Enhanced quinpirole responses in rats lesioned neonatally with 5,7-dihydroxytryptamine. Pharmacol Biochem Behav 50:649\u2013653","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR8","first-page":"324","volume":"3","author":"R Brus","year":"1997","unstructured":"Brus R, Szkilnik R, Kostrzewa RM (1997) Quinpirole-induced yawning behavior in rats neonatally pretreated with 6-hydroxydopamine (6-OHDA) and 5,7-dihydroxytryptamine (5,7-DHT). Med Sci Monitor 3:324\u2013327","journal-title":"Med Sci Monitor"},{"key":"9192_CR9","first-page":"25","volume":"10","author":"R Brus","year":"1998","unstructured":"Brus R, Szkilnik R, Nowak P, Kasperska A, Oswiecimska J, Kostrzewa RM, Shani J (1998) Locomotor sensitization of dopamine receptors by their agonists quinpirole and SKF-38393, during maturation and aging in rats. Pharmacol Rev Commun 10:25\u201330","journal-title":"Pharmacol Rev Commun"},{"issue":"5","key":"9192_CR10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF03033153","volume":"5","author":"R Brus","year":"2003","unstructured":"Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP (2003) Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Neurotox Res 5(5):329\u2013338","journal-title":"Neurotox Res"},{"key":"9192_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF03033442","volume":"6","author":"R Brus","year":"2004","unstructured":"Brus R, Nowak P, Szkilnik R, Miko\u0142ajun U, Kostrzewa RM (2004) Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox Res 6:317\u2013325","journal-title":"Neurotox Res"},{"key":"9192_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1523\/JNEUROSCI.09-01-00125.1989","volume":"9","author":"H Criswell","year":"1989","unstructured":"Criswell H, Mueller RA, Breese GR (1989) Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J Neurosci 9:125\u2013133","journal-title":"J Neurosci"},{"key":"9192_CR13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(92)90383-Q","volume":"41","author":"L Gong","year":"1992","unstructured":"Gong L, Kostrzewa RM (1992) Supersensitized oral response to a serotonin agonist in neonatal 6-OHDA treated rats. Pharmacol Biochem Behav 41:621\u2013623","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-3565(25)11111-7","volume":"261","author":"L Gong","year":"1992","unstructured":"Gong L, Kostrzewa RM, Fuller RW, Perry KW (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 261:1000\u20131007","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-3806(93)90122-Q","volume":"76","author":"L Gong","year":"1993","unstructured":"Gong L, Kostrzewa RM, Brus R, Fuller RW, Perry KW (1993a) Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. Dev Brain Res 76:59\u201365","journal-title":"Dev Brain Res"},{"key":"9192_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-3806(93)90211-R","volume":"76","author":"L Gong","year":"1993","unstructured":"Gong L, Kostrzewa RM, Perry KW, Fuller RW (1993b) Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev Brain Res 76:233\u2013238","journal-title":"Dev Brain Res"},{"key":"9192_CR17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1046\/j.1471-4159.1994.63041282.x","volume":"63","author":"L Gong","year":"1994","unstructured":"Gong L, Kostrzewa RM, Li C (1994) Neonatal 6-OHDA and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J Neurochem 63:1282\u20131290","journal-title":"J Neurochem"},{"key":"9192_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00952990902825447","volume":"35","author":"CN Haile","year":"2009","unstructured":"Haile CN, Kosten TR, Kosten TA (2009) Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. Am J Drug Alcohol Abuse 35:161\u2013177 (Review)","journal-title":"Am J Drug Alcohol Abuse"},{"key":"9192_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(91)90798-U","volume":"203","author":"A Hamdi","year":"1991","unstructured":"Hamdi A, Kostrzewa RM (1991) Ontogenic homologous supersensitization of dopamine D1 receptors. Eur J Pharmacol 203:115\u2013120","journal-title":"Eur J Pharmacol"},{"issue":"4 Suppl","key":"9192_CR20","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.5694\/j.1326-5377.2009.tb02370.x","volume":"190","author":"DF Hermens","year":"2009","unstructured":"Hermens DF, Lubman DI, Ward PB, Naismith SL, Hickie IB (2009) Amphetamine psychosis: a model for studying the onset and course of psychosis. Med J Aust 190(4 Suppl):S22\u2013S25 Review","journal-title":"Med J Aust"},{"key":"9192_CR21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3565(24)36400-6","volume":"280","author":"N-Y Huang","year":"1997","unstructured":"Huang N-Y, Kostrzewa RM, Li C, Perry KW, Fuller RW (1997) Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. J Pharmacol Exp Ther 280:268\u2013276","journal-title":"J Pharmacol Exp Ther"},{"key":"9192_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(94)00019-W","volume":"19","author":"RM Kostrzewa","year":"1995","unstructured":"Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19:1\u201317","journal-title":"Neurosci Biobehav Rev"},{"key":"9192_CR23","doi-asserted-by":"crossref","unstructured":"Kostrzewa RM, Brus R (1991a) Is dopamine-agonist induced yawning behavior a D3 mediated event? Pharmacol Lett Section Life Sci 48: PL-129.","DOI":"10.1016\/0024-3205(91)90619-M"},{"key":"9192_CR24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0091-3057(91)90219-R","volume":"39","author":"RM Kostrzewa","year":"1991","unstructured":"Kostrzewa RM, Brus R (1991b) Ontogenic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol Biochem Behav 39:517\u2013519","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-3057(91)90146-S","volume":"39","author":"RM Kostrzewa","year":"1991","unstructured":"Kostrzewa RM, Gong L (1991) Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Pharmacol Biochem Behav 39:677\u2013682","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0091-3057(91)90614-8","volume":"38","author":"RM Kostrzewa","year":"1991","unstructured":"Kostrzewa RM, Hamdi A (1991) Potentiation of spiroperidol-induced oral activity in rats after neonatal 6-hydroxydopamine. Pharmacol Biochem Behav 38:215\u2013218","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0091-3057(93)90534-Z","volume":"45","author":"RM Kostrzewa","year":"1993","unstructured":"Kostrzewa RM, Neely D (1993) Enhanced pilocarpine-induced oral activity responses in neonatal 6-OHDA treated rats. Pharmacol Biochem Behav 45:737\u2013740","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0014-2999(90)94542-6","volume":"183","author":"RM Kostrzewa","year":"1990","unstructured":"Kostrzewa RM, Hamdi A, Kostrzewa FP (1990) Production of prolonged supersensitization of dopamine D2 receptors. Eur J Pharmacol 183:1411\u20131412","journal-title":"Eur J Pharmacol"},{"key":"9192_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(91)90164-L","volume":"209","author":"RM Kostrzewa","year":"1991","unstructured":"Kostrzewa RM, Brus R, Kalbfleisch J (1991) Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats. Eur J Pharmacol 209:157\u2013161","journal-title":"Eur J Pharmacol"},{"key":"9192_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0091-3057(93)90496-G","volume":"44","author":"RM Kostrzewa","year":"1993","unstructured":"Kostrzewa RM, Brus R, Rykaczewska M, Plech A (1993a) Low dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol Biochem Behav 44:487\u2013489","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(93)90992-Q","volume":"239","author":"RM Kostrzewa","year":"1993","unstructured":"Kostrzewa RM, Guo J, Kostrzewa FP (1993b) Ontogenetic quinpirole treatments induce vertical jumping activity in rats. Eur J Pharmacol 239:183\u2013187","journal-title":"Eur J Pharmacol"},{"key":"9192_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-3806(93)90126-U","volume":"76","author":"RM Kostrzewa","year":"1993","unstructured":"Kostrzewa RM, Brus R, Perry KW, Fuller RW (1993c) Age-dependence of a 6-hydroxydopamine lesion on SKF 38393-, m-chlorophenylpiperazine-induced oral activity responses of rats. Dev Brain Res 76:87\u201393","journal-title":"Dev Brain Res"},{"key":"9192_CR34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0361-9230(94)90013-2","volume":"34","author":"RM Kostrzewa","year":"1994","unstructured":"Kostrzewa RM, Brus R, Kalbflesich JH, Perry KW, Fuller RW (1994) Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34:161\u2013167","journal-title":"Brain Res Bull"},{"key":"9192_CR35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.1998.70030889.x","volume":"70","author":"RM Kostrzewa","year":"1998","unstructured":"Kostrzewa RM, Reader TA, Descarries L (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J Neurochem 70:889\u2013898","journal-title":"J Neurochem"},{"key":"9192_CR36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03033376","volume":"5","author":"RM Kostrzewa","year":"2003","unstructured":"Kostrzewa RM, Kostrzewa JP, Brus R (2003) Dopamine receptor supersensitivity: an outcome and index of neurotoxicity. Neurotox Res 5:111\u2013118","journal-title":"Neurotox Res"},{"key":"9192_CR37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF03033281","volume":"6","author":"RM Kostrzewa","year":"2004","unstructured":"Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R (2004) Dopamine D2 agonist priming in intact and dopamine-lesioned rats. Neurotox Res 6:457\u2013462","journal-title":"Neurotox Res"},{"key":"9192_CR38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00726-005-0162-4","volume":"28","author":"RM Kostrzewa","year":"2005","unstructured":"Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R (2005) Peculiarities of l-DOPA treatment of Parkinson\u2019s disease. Amino Acids 28:157\u2013164","journal-title":"Amino Acids"},{"issue":"1","key":"9192_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03033481","volume":"11","author":"RM Kostrzewa","year":"2007","unstructured":"Kostrzewa RM, Huang N-Y, Kostrzewa JP, Nowak P, Brus R (2007) Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res 11(1):41\u201350","journal-title":"Neurotox Res"},{"key":"9192_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF03033804","volume":"14","author":"RM Kostrzewa","year":"2008","unstructured":"Kostrzewa RM, Kostrzewa JP, Brown R, Nowak P, Brus R (2008) Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability. Neurotox Res 14:121\u2013128","journal-title":"Neurotox Res"},{"key":"9192_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2004.02.013","volume":"78","author":"SS Moy","year":"2004","unstructured":"Moy SS, Fernandes A, Qian Y, Rotella DL, Kostrzewa RM, Breese GR (2004) Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss. Pharmacol Biochem Behav 78:47\u201356","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR42","first-page":"319","volume":"53","author":"P Nowak","year":"2001","unstructured":"Nowak P, Brus R, Kostrzewa RM (2001) Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol J Pharmacol 53:319\u2013329","journal-title":"Pol J Pharmacol"},{"key":"9192_CR43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbb.2006.03.024","volume":"84","author":"P Nowak","year":"2006","unstructured":"Nowak P, Labus \u0141, Kostrzewa RM, Brus R (2006) DSP-4 prevents dopamine receptor priming by quinpirole. Pharmacol Biochem Behav 84:3\u20137","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF03033391","volume":"11","author":"P Nowak","year":"2007","unstructured":"Nowak P, Bortel A, Dabrowska J, Oswiecimska J, Drosik M, Kwiecinski A, Opara J, Kostrzewa RM, Brus R (2007) Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. Neurotox Res 11:131\u2013144","journal-title":"Neurotox Res"},{"key":"9192_CR45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1734-1140(09)70037-4","volume":"57","author":"P Nowak","year":"2009","unstructured":"Nowak P, Bortel A, Kwieci\u0144ski A, Jo\u015bko J, Kostrzewa RM, Brus R (2009a) Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists. Pharm Rep 57:311\u2013318","journal-title":"Pharm Rep"},{"key":"9192_CR46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1734-1140(09)70037-4","volume":"61","author":"P Nowak","year":"2009","unstructured":"Nowak P, Nitka D, Kwieci\u0144ski A, Jo\u015bko J, Drab J, Pojda-Wilczek D, Kasperski J, Kostrzewa RM, Brus R (2009b) Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists. Pharm Rep 61:311\u2013318","journal-title":"Pharm Rep"},{"key":"9192_CR47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-3057(00)00296-3","volume":"67","author":"J Oswiecimska","year":"2000","unstructured":"Oswiecimska J, Brus R, Szkilnik R, Nowak P, Kostrzewa RM (2000) 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats. Pharmacol Biochem Behav 67:11\u201315","journal-title":"Pharmacol Biochem Behav"},{"key":"9192_CR48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03033800","volume":"14","author":"T Palomo","year":"2008","unstructured":"Palomo T, Kostrzewa RM, Beninger RJ, Archer T (2008) Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyringhs. Neurotox Res 14:79\u201396","journal-title":"Neurotox Res"},{"key":"9192_CR49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF02245863","volume":"119","author":"A Plech","year":"1995","unstructured":"Plech A, Brus R, Kalbfleisch JH, Kostrzewa RM (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology 119:466\u2013473","journal-title":"Psychopharmacology"},{"key":"9192_CR50","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/0024-3205(83)90155-8","volume":"33","author":"H Rosengarten","year":"1983","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in na\u00efve rats by D1 stimulation. Life Sci 33:2479\u20132482","journal-title":"Life Sci"},{"key":"9192_CR51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4899-2723-1_11","volume":"235","author":"H Rosengarten","year":"1986","unstructured":"Rosengarten H, Schweitzer JW, Egawa J, Friedhoff AJ (1986) Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements. Adv Exp Med Biol 235:159\u2013167","journal-title":"Adv Exp Med Biol"},{"key":"9192_CR52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","volume":"1","author":"P Seeman","year":"1987","unstructured":"Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133\u2013152","journal-title":"Synapse"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-010-9192-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-010-9192-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-010-9192-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:13:56Z","timestamp":1740021236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-010-9192-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,22]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["9192"],"URL":"https:\/\/doi.org\/10.1007\/s12640-010-9192-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,22]]}}}